Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins

• 收藏
• 分享

专利权人:

SANOFI

发明人:

Isabel MUHLEN-BARTMER,Monika ZIEMEN

申请号：

US16700541

公开号：

US20200170945A1

申请日:

2019.12.02

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The application relates to an aqueous pharmaceutical formulation for use in the treatment of Type I or Type II Diabetes Mellitus, wherein the treatment reduces the risk of nocturnal hypoglycemia, said formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/